<![CDATA[FDA Clears IND For UGN-501 in Non-Muscle Invasive Bladder Cancer]]>

<![CDATA[Pembrolizumab Plus EV Regimens Receive FDA Approval for Muscle Invasive Bladder Cancer]]>

FDA Expands Approval of Chemo-Free Bladder Cancer Combo in Curative Setting

(MedPage Today) -- The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with

<![CDATA[Isatuximab Wins FDA Approval, Becoming Second Subcutaneous Anti-CD38 for Multiple Myeloma]]>

PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer

Conditions : Bladder Cancer Interventions : Drug: PTC guided individualized neoadjuvant therapy Sponsors : The Affiliated Nanjing Drum Tower

Nectin4-targeted fluorescence imaging probe improves bladder cancer detection and surgical precision

He et al. develop NECTIN4-ICG, a Nectin4-targeted fluorescence imaging probe for bladder cancer. In preclinical models and clinical trials,

Natera MRD Test for Bladder Cancer Nabs Top-Level US Recommendation

The National Comprehensive Cancer Network has given Signatera a Category 1 recommendation in updated clinical practice guidelines.